Introduction on Cardiac Resynchronisation Therapy and Heart Failure: Perspective from 5P Medicine

Add this Moment to your Passport

Learn from this moment and keep it forever.
FREE
Add To Passport

Preview

Summary

Introduction on Cardiac Resynchronisation Therapy and Heart Failure: Perspective from 5P Medicine

The prevalence of heart failure (HF) is still high1 and is rising in developing countries.2 Despite optimal medical therapy, refractory HF is a common occurrence and remains a “global disease requiring global response.”3 The emergence of cardiac resynchronisation therapy (CRT), has brought a new paradigm in the management of HF. CRT has been the most promising device therapy in mild-to-severe HF over the past two decades,4 has improved the prognosis of HF and has been incorporated into therapeutic guidelines.5,6 The 20-year history of CRT illustrates the concept of “from bench to bedside” and this article aims to review the use of CRT in the context of 5P medicine-prevention, personalisation, prediction and participation as well as promotion.

Loading Simple Education